ArticleEuropean journal of case reports in internal medicine2025
From Fluttering Hearts to Restless Stomach: Navigating Atrial Fibrillation, Ablation and Gastroparesis.
Article in European journal of case reports in internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We present a case of severe gastroparesis with pyloric spasm secondary to radiofrequency catheter ablation (RFCA) with a focus on procedural risk factors, prevention, and treatment modalities. Case report: A 39-year-old man with paroxysmal atrial fibrillation underwent RFCA after failed pharmaceutical treatment. The procedure involved three-dimensional mapping and controlled RFCA near the oesophagus. Post-procedure, he developed severe abdominal pain, distention, and vomiting. Imaging revealed stomach distention and pyloric spasm. An upper endoscopy confirmed gastroparesis due to ablation. Metoclopramide was administered, improving food tolerance. However, persistent symptoms led to a gastric emptying study showing delayed emptying, consistent with gastroparesis. Despite treatment with metoclopramide, the patient's symptoms persisted, prompting consideration of esophageal botulinum toxin and medication changes for symptom management. Conclusions: In a patient with no prior history of abdominal symptoms or chronic gastric disorder post ablation presentation of new-onset abdominal distention, pain, and vomiting ablation-induced gastroparesis should be high on the differential and different treatment modalities should be tried if severe symptoms such as postprandial regurgitation persist. Moreover, better oesophageal protection strategies should be implemented, and guidelines be added to procedure performance limiting excessive force, energy, manipulation, and introduction of oesophageal temperature control holding parameters. LEARNING POINTS: Gastroparesis can be an under-recognized complication of left atrial ablation.Posterior wall ablation near the oesophagus is high-risk for gastrointestinal complications.Symptoms usually persist for 3-6 months but may last long term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.